Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 11/2010

01-11-2010 | Original Research

Real-life dosage and clinical efficacy of biphasic insulin preparations in patients with type 2 diabetes

Authors: Walid K. H. Fakhoury, Hartmut Richter, Torsten E. Christensen

Published in: Advances in Therapy | Issue 11/2010

Login to get access
Metadata
Title
Real-life dosage and clinical efficacy of biphasic insulin preparations in patients with type 2 diabetes
Authors
Walid K. H. Fakhoury
Hartmut Richter
Torsten E. Christensen
Publication date
01-11-2010
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 11/2010
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-010-0079-5

Other articles of this Issue 11/2010

Advances in Therapy 11/2010 Go to the issue

Review

The role of quetiapine extended release in the treatment of bipolar depression

Review

Improving medication compliance in patients with depression: Use of orodispersible tablets

Review

Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy

Original Research

The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder

Original Research

Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China

Original Research

Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits